OneBreath™ by Breath Diagnostics: The Simply Superior Breath Analysis Solution
OneBreath™ by Breath Diagnostics is a non-invasive breath analysis that uses a unique microreactor for quick UHPLC-MS analysis, setting a new standard for breath diagnostics.

Breath analysis has long held the promise of revolutionizing diagnostics, particularly in detecting diseases like lung cancer through non-invasive means. However, despite decades of research, traditional breath analysis has struggled to gain widespread clinical adoption. The core issue? A lack of standardization in sampling, pre-concentration, and analysis methods.
Enter OneBreath™ by Breath Diagnostics (BDx)—a game-changing technology that overcomes the pitfalls of traditional breath analysis while providing unparalleled accuracy, reliability, and ease of use. Let’s explore why OneBreath™ is simply superior to other breath analysis methods.
The Challenges of Traditional Breath Analysis
Before we dive into OneBreath™’s innovation, let’s look at the shortcomings of traditional breath analysis:
1. Lack of Standardization in Sampling
Breath composition varies significantly based on how it is collected. Traditional methods distinguish between:
- End-tidal breath (deep lung air)
- Late expiratory breath (includes upper airways)
- Mixed expiratory breath (a blend of lung and oral cavity air)
These variations introduce inconsistencies in biomarker concentration measurements, making it difficult to establish reliable diagnostic thresholds.
2. Pre-Concentration Problems
Breath biomarkers exist in extremely low concentrations, requiring pre-concentration techniques before analysis. Traditional methods rely on sorbent tubes, such as:
- Thermal desorption tubes
- Solid-phase microextraction (SPME)
- Needle trap devices (NTDs)
These methods introduce contamination risks and sample degradation, leading to inconsistent and unreliable results.
3. Inefficiencies in Ionization and Analysis
Gas chromatography-mass spectrometry (GC-MS) remains the gold standard for breath biomarker validation, but it has limitations:
- Thermal degradation risk due to heating during desorption
- Loss of VOCs during transfer
- Inconsistent ionization efficiency
- Extremely slow analysis times—GC-MS takes up to an hour per sample
These drawbacks have hindered traditional breath analysis from becoming a routine diagnostic tool.
How OneBreath™ is Simply Superior
OneBreath™ completely redefines breath analysis by addressing these long-standing challenges. With a patented microreactor technology, it enables a more efficient, standardized, and accurate diagnostic process.
1. Standardization Through One Exhale
OneBreath™ streamlines sampling by requiring just one exhale into a Tedlar® bag. This single-breath approach ensures that every sample contains a standardized concentration of volatile organic compounds (VOCs), solving a major issue in breath diagnostics.
Eliminates variability in sampling
- Ensures precise biomarker concentration measurements
- Enhances reproducibility and clinical reliability
With OneBreath™, we no longer need to worry about sampling inconsistencies—it’s a single, controlled breath every time.
2. Smart VOC Capturing with a Novel Microreactor
Instead of relying on traditional adsorption-based trapping, where VOCs are physically stuck onto surfaces and later released by heating (which can cause sample degradation), OneBreath™ chemically derivatizes VOCs into adducts.
Why is this better? The microreactor forms stable cationic adducts, which are chemically bound rather than physically trapped. This:
- Prevents sample loss
- Reduces contamination risks
- Improves measurement sensitivity
3. Breakthrough Ionization for Ultra-Sensitive Analysis
Unlike GC-MS, which requires thermal desorption, OneBreath™’s microreactor method enhances ionization efficiency, making analysis both easier and more reliable.
Traditional VOC trapping (Desorption Tubes):
- VOCs are physically adsorbed and require heating to be released
- Heating can cause fragmentation and loss of biomarkers
- Requires additional sample preparation steps
OneBreath™ Technology (BDx Derivatization):
- VOCs form stable cationic adducts instead of being adsorbed
- These adducts are already ionized, making mass spectrometry analysis far more sensitive and accurate
- Cold solvent rinsing (not heat) releases VOCs, eliminating concerns over thermal degradation
4. The Ultimate Analytical Advantage: No Thermal Desorption Required
OneBreath™ uses UHPLC-MS (Ultra-High-Performance Liquid Chromatography-Mass Spectrometry) for biomarker detection, offering significant advantages:
- No thermal degradation – samples remain intact
- No additional sample preparation needed – no complex desorption steps
- All adducts are positively charged – ensures consistent and efficient ionization
5. Commercial Throughput: OneBreath™ is 10x Faster
One of the biggest challenges in traditional breath analysis is processing time. Traditional methods are slow and inefficient, making high-volume testing commercially unfeasible.
Traditional Analysis: Slow and Inefficient
- GC-MS analysis can take upwards of 1 hour per sample
- Patient sampling with desorption tubes takes 15–30 minutes
- Throughput is low, making large-scale implementation impractical
OneBreath™: Built for Speed and Scalability
- UHPLC-MS analysis takes less than 10 minutes per sample
- Patient sampling takes only 30 seconds
- Enables high-throughput diagnostics, making breath analysis commercially viable
What does this mean? OneBreath™ is significantly faster and more feasible for real-world applications, making it the first truly scalable breath analysis technology.
The Future of Breath Analysis is Here
With OneBreath™, Breath Diagnostics has transformed a major industry challenge into its biggest strength. By tackling standardization, sample integrity, and ionization efficiency, OneBreath™ makes breath analysis:
- More reliable – Controlled, standardized sampling eliminates errors
- More accurate – Derivatization ensures ultra-sensitive biomarker detection
- More efficient – No need for complex sample preparation or thermal desorption
- 10x Faster – Ultra-fast sampling and analysis enable real-world implementation
Traditional breath analysis has struggled with consistency and practicality—but with OneBreath™, the future of breath diagnostics is now a reality.
Ready to see the future of non-invasive diagnostics? Stay tuned as Breath Diagnostics continues to revolutionize breath analysis technology.
Ready to Transform Lung Cancer Screening? Discover the Future Today.
Watch our video to learn how OneBreath™ is revolutionizing diagnostics with life-saving precision and simplicity.
